ID: ALA11081

Max Phase: Preclinical

Molecular Formula: C11H18N2O

Molecular Weight: 194.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N(C)CC#CCN1CCCC1

Standard InChI:  InChI=1S/C11H18N2O/c1-11(14)12(2)7-3-4-8-13-9-5-6-10-13/h5-10H2,1-2H3

Standard InChI Key:  HWYHDWGGACRVEH-UHFFFAOYSA-N

Associated Targets(Human)

Muscarinic acetylcholine receptor M3 7750 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor 1128 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M1 12690 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Muscarinic acetylcholine receptor 3770 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M4 559 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M3 655 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M2 1011 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cavia porcellus 23802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A9 98 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M3 70 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

cyclic AMP phosphoprotein 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 194.28Molecular Weight (Monoisotopic): 194.1419AlogP: 0.56#Rotatable Bonds: 2
Polar Surface Area: 23.55Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.18CX LogP: 0.32CX LogD: -0.53
Aromatic Rings: 0Heavy Atoms: 14QED Weighted: 0.60Np Likeness Score: -1.32

References

1. Bradbury BJ, Baumgold J, Paek R, Kammula U, Zimmet J, Jacobson KA..  (1991)  Muscarinic receptor binding and activation of second messengers by substituted N-methyl-N-[4-(1-azacycloalkyl)-2-butynyl]acetamides.,  34  (3): [PMID:1848294] [10.1021/jm00107a029]
2. Moon MW, Chidester CG, Heier RF, Morris JK, Collins RJ, Russell RR, Francis JW, Sage GP, Sethy VH..  (1991)  Cholinergic activity of acetylenic imidazoles and related compounds.,  34  (8): [PMID:1875333] [10.1021/jm00112a002]
3. Nilsson BM, Ringdahl B, Hacksell U..  (1988)  Derivatives of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.,  31  (3): [PMID:3346873] [10.1021/jm00398a015]
4. Bradbury BJ, Baumgold J, Jacobson KA..  (1990)  Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,  33  (2): [PMID:2153827] [10.1021/jm00164a044]
5. Sanders KB, Thomas AJ, Pavia MR, Davis RE, Coughenour LL, Myers SL, Fisher S, Moos WH.  (1992)  Cholinergic agents: aldehyde, ketone, and oxime analogues of the muscarinic agonist UH5,  (8): [10.1016/S0960-894X(00)80535-1]

Source